Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.93

-0.2%

12:13 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: IRWIN JAMES FRANKEL who wrote (3901)	5/29/2001 3:29:17 PM
From: Biomaven	of 52153

SCIO - The shorts clearly had the best of the risk/ reward ratio. One issue here is that the approval vote was widely expected - remember the stock is already up from the single digits. I did expect a little more of a pop, though. There are also some know-nothings saying that because they already got approval from an AC once and were turned down by the FDA they are not out of the approval woods yet. There's also the issue of an offering waiting in the wings. Going forward, a lot will depend on the pharmo-economic study they are running. Can't say I really anticipate a rapid ramp-up though. Peter

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next